Consun Pharmaceutical Group Limited (FRA:C1P)

FRA:C1P Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,908	2,748	2,450	2,196	1,940
Short-Term Investments	958	834.94	589.17	230	-
Cash & Short-Term Investments	3,866	3,583	3,039	2,426	1,940
Cash Growth	7.88%	17.89%	25.26%	25.05%	40.27%
Accounts Receivable	297.57	255.84	259.56	351.23	448.54
Other Receivables	72.55	54.13	36.1	18.34	9.89
Receivables	370.12	309.97	295.66	369.57	458.43
Inventory	315.51	384.91	287.66	257.62	227.37
Restricted Cash	-	-	-	2.32	-
Other Current Assets	-	-	-	-	32.62
Total Current Assets	4,551	4,278	3,623	3,056	2,659
Property, Plant & Equipment	925.54	863.71	875	858.45	799.45
Long-Term Investments	29.08	9.23	6.5	-	-
Other Intangible Assets	268.96	283.14	311.9	341.66	371.42
Long-Term Deferred Tax Assets	12.52	17.84	36.43	46.86	58.89
Other Long-Term Assets	65.67	55.99	39.87	59.94	61.8
Total Assets	5,853	5,508	4,892	4,363	3,950
Accounts Payable	75.64	83.1	59.89	66.64	50.89
Accrued Expenses	736.12	638.76	566.13	465.53	406.42
Current Portion of Long-Term Debt	253.34	503.42	450.52	599.3	549.41
Current Portion of Leases	6.42	4.22	3.71	3.12	-
Current Income Taxes Payable	47.63	43.38	32.89	2.54	71.11
Current Unearned Revenue	60.82	17.56	39.98	21.21	15.49
Other Current Liabilities	190.83	204.57	197.37	199.07	238.55
Total Current Liabilities	1,371	1,495	1,350	1,357	1,332
Long-Term Leases	7.41	3.9	5.95	8.55	-
Long-Term Unearned Revenue	14.64	19.18	18.93	16.7	15.63
Long-Term Deferred Tax Liabilities	67.19	71.21	78.01	69.3	86.26
Total Liabilities	1,460	1,589	1,453	1,452	1,434
Common Stock	67.31	63.81	63.45	64.8	64.42
Additional Paid-In Capital	216.46	18.15	-	19.79	-
Retained Earnings	3,650	3,381	2,913	2,393	2,003
Treasury Stock	-	-83.17	-83.17	-113.32	-88.64
Comprehensive Income & Other	163.67	247.15	251.7	253.89	241.38
Total Common Equity	4,098	3,627	3,145	2,618	2,220
Minority Interest	295.45	292.21	293.87	293.08	296.13
Shareholders' Equity	4,393	3,919	3,439	2,911	2,516
Total Liabilities & Equity	5,853	5,508	4,892	4,363	3,950
Total Debt	267.17	511.53	460.18	610.97	549.41
Net Cash (Debt)	3,599	3,072	2,579	1,815	1,391
Net Cash Growth	17.15%	19.10%	42.08%	30.52%	67.64%
Net Cash Per Share	4.32	3.84	3.26	2.26	1.70
Filing Date Shares Outstanding	830.83	792.43	788.39	805.64	799.83
Total Common Shares Outstanding	830.83	792.43	788.39	805.64	799.83
Working Capital	3,181	2,783	2,272	1,698	1,327
Book Value Per Share	4.93	4.58	3.99	3.25	2.78
Tangible Book Value	3,829	3,343	2,833	2,276	1,849
Tangible Book Value Per Share	4.61	4.22	3.59	2.83	2.31
Buildings	399.2	338.28	334.82	334.1	333.15
Machinery	363.52	324.86	302.16	282.15	269
Construction In Progress	412.24	416.43	416.01	381.67	314.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.